Mpm Asset Management as of Sept. 30, 2014
Portfolio Holdings for Mpm Asset Management
Mpm Asset Management holds 13 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Radius Health | 40.1 | $123M | 5.8M | 21.00 | |
| Epizyme | 21.4 | $65M | 2.4M | 27.11 | |
| Portola Pharmaceuticals | 10.1 | $31M | 1.2M | 25.28 | |
| Trivascular Technologies | 8.4 | $26M | 1.8M | 14.48 | |
| Aratana Therapeutics | 7.0 | $21M | 2.1M | 10.04 | |
| PharmAthene | 3.7 | $11M | 6.3M | 1.78 | |
| Celladon | 3.6 | $11M | 1.1M | 10.46 | |
| Conatus Pharmaceuticals | 2.4 | $7.3M | 1.2M | 6.12 | |
| Verastem | 2.3 | $7.0M | 817k | 8.52 | |
| Mast Therapeutics | 0.5 | $1.4M | 2.6M | 0.56 | |
| EnteroMedics | 0.5 | $1.4M | 1.1M | 1.23 | |
| Sangamo Biosciences (SGMO) | 0.1 | $243k | 23k | 10.81 | |
| Macrogenics (MGNX) | 0.0 | $66k | 3.2k | 20.83 |
